تداول BioCryst - BCRX CFD
أضف إلى اللائحة المفضلة- الملخص
- بيانات الفترات السابقة
- الاحداث
- بيان الدخل
- كشف الميزانية
- التدفق النقدي
- الملكية
شروط التداول
| الفارق | 0.07 | ||||||||
|
رسوم التبييت على مركز الشراء
Long position overnight fee
الذهاب إلى المنصة | -0.030779% | ||||||||
|
رسوم التبييت على مركز البيع
Short position overnight fee
الذهاب إلى المنصة | -0.013666% | ||||||||
| اوقات رسوم التبييت | 22:00 (UTC) | ||||||||
| الحد الأدنى للكمية المتداولة | 1 | ||||||||
| العملة | USD | ||||||||
| الهامش | 20% | ||||||||
| تداول الاسهم | United States of America | ||||||||
| عمولة على التداول | 0% |
*Information provided by Capital.com
الإحصائيات الرئيسية
| إقفال سابق* | 10.72 |
| مفتوح* | 10.7 |
| تغيير سنة* | -28.67% |
| نطاق اليوم* | 10.49 - 10.7 |
| في نطاق 52 أسبوعا | 7.61-19.99 |
| متوسط الحجم (10 أيام) | 2.05M |
| متوسط الحجم (3 أشهر) | 54.89M |
| القيمة السوقية | 2.00B |
| السهم/ربحية السهم | -100.00K |
| الأسهم القائمة | 186.42M |
| عائد | 238.44M |
| EPS | -1.04 |
| الأرباح الموزعة (الحصيلة٪) | N/A |
| الإصدار التجريبي | 2.00 |
| تاريخ الأرباح القادمة | Feb 21, 2023 |
"يتم توفير جميع البيانات من قبل Refinitiv، باستثناء البيانات التي تحمل علامة النجمة، وهي * البيانات المقدمة من Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | الإغلاق | Change | Change (%) | الفتح | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 10.52 | -0.04 | -0.38% | 10.56 | 10.77 | 10.46 |
| Feb 2, 2023 | 10.72 | 0.18 | 1.71% | 10.54 | 10.83 | 10.45 |
| Feb 1, 2023 | 10.50 | 0.32 | 3.14% | 10.18 | 10.61 | 10.18 |
| Jan 31, 2023 | 10.51 | 0.17 | 1.64% | 10.34 | 10.56 | 10.34 |
| Jan 30, 2023 | 10.31 | -0.18 | -1.72% | 10.49 | 10.58 | 10.27 |
| Jan 27, 2023 | 10.54 | -0.21 | -1.95% | 10.75 | 10.93 | 10.53 |
| Jan 26, 2023 | 10.74 | -0.03 | -0.28% | 10.77 | 10.87 | 10.60 |
| Jan 25, 2023 | 10.75 | 0.04 | 0.37% | 10.71 | 10.99 | 10.54 |
| Jan 24, 2023 | 10.98 | 0.39 | 3.68% | 10.59 | 11.07 | 10.49 |
| Jan 23, 2023 | 10.60 | 0.29 | 2.81% | 10.31 | 10.70 | 10.29 |
| Jan 20, 2023 | 10.35 | 0.35 | 3.50% | 10.00 | 10.44 | 9.93 |
| Jan 19, 2023 | 9.98 | -0.06 | -0.60% | 10.04 | 10.30 | 9.95 |
| Jan 18, 2023 | 10.07 | 0.06 | 0.60% | 10.01 | 10.34 | 9.96 |
| Jan 17, 2023 | 9.97 | -0.13 | -1.29% | 10.10 | 10.16 | 9.91 |
| Jan 13, 2023 | 10.12 | -0.01 | -0.10% | 10.13 | 10.42 | 10.02 |
| Jan 12, 2023 | 10.28 | 0.49 | 5.01% | 9.79 | 10.30 | 9.79 |
| Jan 11, 2023 | 9.99 | -0.64 | -6.02% | 10.63 | 10.63 | 9.92 |
| Jan 10, 2023 | 10.64 | 0.16 | 1.53% | 10.48 | 10.77 | 10.39 |
| Jan 9, 2023 | 10.60 | -0.59 | -5.27% | 11.19 | 11.19 | 9.52 |
| Jan 6, 2023 | 11.79 | 0.03 | 0.26% | 11.76 | 12.04 | 11.57 |
BioCryst Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| إجمالي الإيرادات | 26.353 | 25.186 | 20.653 | 48.835 | 17.812 | 157.17 |
| عائد | 26.353 | 25.186 | 20.653 | 48.835 | 17.812 | 157.17 |
| تكلفة الإيرادات، الإجمالي | 2.699 | 1.702 | 0.471 | 4.101 | 1.676 | 7.264 |
| إجمالي الربح | 23.654 | 23.484 | 20.182 | 44.734 | 16.136 | 149.906 |
| جمالي المصاريف التشغيلية | 74.96 | 82.597 | 114.873 | 148.29 | 194.58 | 279.052 |
| مصاريف البيع/النفقات العامة/الإدارية، المجموع | 11.253 | 13.933 | 13.614 | 37.121 | 67.929 | 118.818 |
| البحث والتطوير | 61.008 | 66.962 | 84.888 | 107.068 | 122.964 | 208.808 |
| الدخل التشغيلي | -48.607 | -57.411 | -94.22 | -99.455 | -176.768 | -121.882 |
| إيرادات الفوائد (المصروفات)، صافي الإيرادات غير التشغيلية | -6.537 | -8.371 | -7.032 | -9.442 | -6.046 | -59.927 |
| صافي الدخل قبل الضرائب | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -181.809 |
| صافي الدخل بعد الضرائب | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| صافي الدخل قبل الإضافات. العناصر | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| صافي الدخل | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| الدخل المتاح للمشترك باستثناء الإضافات. العناصر | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| الدخل المتاح للمشترك بما في ذلك الإضافي. العناصر | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| صافي الدخل المخفف | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| المتوسط المرجح المخفف للأسهم | 73.699 | 84.451 | 103.185 | 115.6 | 167.267 | 179.117 |
| عائد السهم المخفف باستثناء العناصر غير العادية | -0.74823 | -0.77894 | -0.98127 | -0.94202 | -1.09295 | -1.02761 |
| Dividends per Share - Common Stock Primary Issue | 0 | |||||
| الأرباح العادية المخففة للسهم الواحد | -0.74823 | -0.77894 | -0.82717 | -0.94202 | -1.08092 | -1.23024 |
| مجموع البنود الاستثنائية | 0 | |||||
| مصاريف غير اعتيادية (دخل) | 15.9 | 2.011 | -55.838 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| إجمالي الإيرادات | 19.059 | 49.959 | 40.994 | 47.158 | 49.923 |
| عائد | 19.059 | 49.959 | 40.994 | 47.158 | 49.923 |
| تكلفة الإيرادات، الإجمالي | 5.887 | 0.343 | 0.615 | 0.419 | 0.238 |
| إجمالي الربح | 13.172 | 49.616 | 40.379 | 46.739 | 49.685 |
| جمالي المصاريف التشغيلية | 70.436 | 79.541 | 85.578 | 43.497 | 99.88 |
| مصاريف البيع/النفقات العامة/الإدارية، المجموع | 22.114 | 26.325 | 34.992 | 35.387 | 34.282 |
| البحث والتطوير | 42.435 | 52.873 | 49.971 | 63.529 | 65.36 |
| الدخل التشغيلي | -51.377 | -29.582 | -44.584 | 3.661 | -49.957 |
| إيرادات الفوائد (المصروفات)، صافي الإيرادات غير التشغيلية | -12.907 | -13.616 | -14.217 | -19.187 | -23.96 |
| صافي الدخل قبل الضرائب | -64.284 | -43.198 | -58.801 | -15.526 | -73.917 |
| صافي الدخل بعد الضرائب | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| صافي الدخل قبل الإضافات. العناصر | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| صافي الدخل | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| الدخل المتاح للمشترك باستثناء الإضافات. العناصر | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| الدخل المتاح للمشترك بما في ذلك الإضافي. العناصر | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| صافي الدخل المخفف | -64.284 | -43.198 | -58.801 | -17.779 | -74.196 |
| المتوسط المرجح المخفف للأسهم | 177.343 | 178.127 | 179.106 | 181.871 | 184.898 |
| عائد السهم المخفف باستثناء العناصر غير العادية | -0.36248 | -0.24251 | -0.3283 | -0.09776 | -0.40128 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| الأرباح العادية المخففة للسهم الواحد | -0.36248 | -0.24251 | -0.3283 | -0.29732 | -0.40128 |
| مصاريف غير اعتيادية (دخل) | -55.838 |
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| إجمالي الأصول المتداولة | 66.987 | 125.391 | 114.352 | 164.345 | 323.8 | 566.136 |
| النقد والاستثمارات قصيرة الأجل | 54.65 | 114.397 | 104.467 | 136.226 | 300.366 | 507.601 |
| النقد وما يعادله | 22.104 | 50.282 | 26.731 | 114.172 | 272.127 | 504.389 |
| استثمارات قصيرة الأجل | 32.546 | 64.115 | 77.736 | 22.054 | 28.239 | 3.212 |
| مجموع المستحقات، صافي | 8.768 | 6.117 | 4.293 | 22.146 | 8.646 | 29.413 |
| Accounts Receivable - Trade, Net | 8.768 | 6.117 | 4.293 | 22.146 | 8.646 | 29.413 |
| Total Inventory | 0.5 | 1.649 | 0 | 7.039 | 15.791 | |
| Prepaid Expenses | 1.438 | 1.381 | 2.39 | 4.422 | 5.528 | 9.986 |
| Other Current Assets, Total | 1.631 | 3.496 | 1.553 | 1.551 | 2.221 | 3.345 |
| Total Assets | 89.847 | 178.259 | 146.841 | 175.282 | 334.715 | 588.151 |
| Property/Plant/Equipment, Total - Net | 9.922 | 9.546 | 9.135 | 10.937 | 10.915 | 15.186 |
| Property/Plant/Equipment, Total - Gross | 14.839 | 14.873 | 15.23 | 18.911 | 20.892 | 25.925 |
| Accumulated Depreciation, Total | -4.917 | -5.327 | -6.095 | -7.974 | -9.977 | -10.739 |
| Long Term Investments | 8.926 | 41.295 | 22.376 | 0 | 6.829 | |
| Other Long Term Assets, Total | 4.012 | 2.027 | 0.978 | |||
| Total Current Liabilities | 54.36 | 74.836 | 69.477 | 92.335 | 105.654 | 103.718 |
| Accounts Payable | 4.269 | 6.337 | 7.769 | 13.988 | 18.713 | 27.808 |
| Accrued Expenses | 19.826 | 24.794 | 27.739 | 37.646 | 56.791 | 74.489 |
| Notes Payable/Short Term Debt | 28.243 | 28.682 | 29.121 | 29.561 | 30 | 0 |
| Other Current Liabilities, Total | 2.022 | 8.484 | 0.221 | 2.12 | 0.15 | 1.421 |
| Total Liabilities | 88.269 | 94.492 | 97.606 | 137.03 | 353.977 | 695.137 |
| Total Long Term Debt | 25.481 | 19.501 | 28.075 | 41.289 | 244.452 | 585.457 |
| Long Term Debt | 22.777 | 16.75 | 25.372 | 41.289 | 244.452 | 585.457 |
| Capital Lease Obligations | 2.704 | 2.751 | 2.703 | |||
| Other Liabilities, Total | 8.428 | 0.155 | 0.054 | 3.406 | 3.871 | 5.962 |
| Total Equity | 1.578 | 83.767 | 49.235 | 38.252 | -19.262 | -106.986 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | |
| Common Stock | 0.738 | 0.984 | 1.101 | 1.541 | 1.769 | 1.843 |
| Additional Paid-In Capital | 566.913 | 714.869 | 780.4 | 877.3 | 1002.41 | 1098.5 |
| Retained Earnings (Accumulated Deficit) | -566.061 | -631.843 | -731.969 | -840.628 | -1023.44 | -1207.5 |
| Other Equity, Total | -0.012 | -0.243 | -0.297 | 0.039 | 0.003 | 0.177 |
| Total Liabilities & Shareholders’ Equity | 89.847 | 178.259 | 146.841 | 175.282 | 334.715 | 588.151 |
| Total Common Shares Outstanding | 73.782 | 98.411 | 110.063 | 154.082 | 176.883 | 184.35 |
| Current Port. of LT Debt/Capital Leases | 6.539 | 4.627 | 9.02 | 0 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| إجمالي الأصول المتداولة | 273.771 | 265.802 | 252.743 | 566.136 | 511.714 |
| النقد والاستثمارات قصيرة الأجل | 240.356 | 218.428 | 199.597 | 507.601 | 443.468 |
| النقد وما يعادله | 226.902 | 210.314 | 199.597 | 504.389 | 395.504 |
| استثمارات قصيرة الأجل | 13.454 | 8.114 | 0 | 3.212 | 47.964 |
| مجموع المستحقات، صافي | 18.386 | 27.62 | 26.212 | 29.413 | 36.415 |
| Accounts Receivable - Trade, Net | 18.386 | 27.62 | 26.212 | 29.413 | 36.415 |
| Total Inventory | 5.113 | 9.846 | 13.663 | 15.791 | 16.144 |
| Prepaid Expenses | 5.908 | 5.56 | 8.975 | 9.986 | 12.333 |
| Other Current Assets, Total | 4.008 | 4.348 | 4.296 | 3.345 | 3.354 |
| Total Assets | 284.431 | 277.284 | 265.763 | 588.151 | 527.72 |
| Property/Plant/Equipment, Total - Net | 10.66 | 11.482 | 13.02 | 15.186 | 16.006 |
| Property/Plant/Equipment, Total - Gross | 6.565 | 5.924 | 7.519 | 9.098 | |
| Accumulated Depreciation, Total | -2.94 | -2.111 | -2.328 | -2.626 | -3.019 |
| Total Current Liabilities | 101.201 | 115.601 | 133.608 | 103.718 | 81.017 |
| Accounts Payable | 13.529 | 10.087 | 19.693 | 27.808 | 13.881 |
| Accrued Expenses | 57.267 | 74.963 | 83.313 | 74.489 | 65.665 |
| Notes Payable/Short Term Debt | 30 | 30 | 30 | 0 | 0 |
| Other Current Liabilities, Total | 0.405 | 0.551 | 0.602 | 1.421 | 1.471 |
| Total Liabilities | 359.419 | 383.359 | 412.807 | 695.137 | 691.935 |
| Total Long Term Debt | 254.335 | 263.658 | 274.164 | 585.457 | 604.461 |
| Long Term Debt | 254.335 | 263.658 | 274.164 | 585.457 | 604.461 |
| Other Liabilities, Total | 3.883 | 4.1 | 5.035 | 5.962 | 6.457 |
| Total Equity | -74.988 | -106.075 | -147.044 | -106.986 | -164.215 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 1.777 | 1.787 | 1.798 | 1.843 | 1.856 |
| Additional Paid-In Capital | 1010.78 | 1022.97 | 1040.77 | 1098.5 | 1115.44 |
| Retained Earnings (Accumulated Deficit) | -1087.73 | -1130.92 | -1189.72 | -1207.5 | -1281.7 |
| Other Equity, Total | 0.182 | 0.087 | 0.114 | 0.177 | 0.186 |
| Total Liabilities & Shareholders’ Equity | 284.431 | 277.284 | 265.763 | 588.151 | 527.72 |
| Total Common Shares Outstanding | 177.67 | 178.725 | 179.791 | 184.35 | 185.572 |
| Long Term Investments | 6.829 | 0 |
- سنوي
- فصلية
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Net income/Starting Line | -55.144 | -65.782 | -101.252 | -108.897 | -182.814 | -184.062 |
| Cash From Operating Activities | -53.438 | -41.143 | -92.565 | -89.584 | -135.108 | -142.157 |
| Cash From Operating Activities | 0.483 | 0.704 | 0.77 | 0.724 | 0.748 | 0.777 |
| Non-Cash Items | 8.774 | 14.608 | 11.447 | 19.461 | 20.083 | 33.004 |
| Changes in Working Capital | -7.551 | 9.327 | -3.53 | -0.872 | 26.875 | 8.124 |
| Cash From Investing Activities | 23.273 | -64.642 | 4.768 | 77.934 | -6.856 | 15.804 |
| Capital Expenditures | -5.277 | -0.328 | -0.366 | -0.343 | -0.514 | -2.385 |
| Other Investing Cash Flow Items, Total | 28.55 | -64.314 | 5.134 | 78.277 | -6.342 | 18.189 |
| Cash From Financing Activities | 23.304 | 135.703 | 62.504 | 99.098 | 300.589 | 359.668 |
| Issuance (Retirement) of Stock, Net | 0.317 | 135.581 | 56.252 | 79.621 | 110.542 | 65.794 |
| Issuance (Retirement) of Debt, Net | 22.987 | 0.122 | 6.252 | 19.477 | 190.047 | 293.874 |
| Net Change in Cash | -6.861 | 29.918 | -25.293 | 87.448 | 158.625 | 233.386 |
| Foreign Exchange Effects | 0.071 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -64.284 | -107.482 | -166.283 | -184.062 | -74.196 |
| Cash From Operating Activities | -61.011 | -86.422 | -109.698 | -142.157 | -77.8 |
| Cash From Operating Activities | 0.178 | 0.377 | 0.606 | 0.777 | 0.317 |
| Non-Cash Items | 16.52 | 35.809 | 62.615 | 33.004 | 28.634 |
| Changes in Working Capital | -13.425 | -15.126 | -6.636 | 8.124 | -32.555 |
| Cash From Investing Activities | 14.673 | 19.177 | 26.924 | 15.804 | -38.472 |
| Capital Expenditures | -0.099 | -0.912 | -1.277 | -2.385 | -0.406 |
| Other Investing Cash Flow Items, Total | 14.772 | 20.089 | 28.201 | 18.189 | -38.066 |
| Cash From Financing Activities | 2.9 | 7.474 | 12.25 | 359.668 | 7.356 |
| Issuance (Retirement) of Stock, Net | 2.9 | 7.474 | 12.25 | 65.794 | 7.356 |
| Net Change in Cash | -43.438 | -59.686 | -70.455 | 233.386 | -108.876 |
| Foreign Exchange Effects | 0.085 | 0.069 | 0.071 | 0.04 | |
| Issuance (Retirement) of Debt, Net | 0 | 293.874 |
| اسم المستثمر | نوع المستثمر | النسبة المئوية المستحقة | الاسهم المملوكة | تغيير الأسهم المملوكة | تاريخ الإمتلاك | معدل العائدات |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.4064 | 13807387 | 28439 | 2022-09-30 | LOW |
| Baker Bros. Advisors LP | Hedge Fund | 6.8182 | 12710818 | 0 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.394 | 11920033 | -185744 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.0446 | 9404247 | -1600556 | 2022-09-30 | LOW |
| Avoro Capital Advisors LLC | Investment Advisor/Hedge Fund | 4.8545 | 9050000 | 2550000 | 2022-09-30 | LOW |
| Fisher Investments | Investment Advisor/Hedge Fund | 2.7699 | 5163845 | -52984 | 2022-09-30 | LOW |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 2.5822 | 4813772 | -1233189 | 2022-09-30 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 2.4284 | 4527037 | 273770 | 2022-09-30 | LOW |
| RP Management, LLC | Private Equity | 2.0631 | 3846154 | 0 | 2022-09-30 | LOW |
| Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.8883 | 3520231 | -1044699 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.8055 | 3365844 | 83687 | 2022-09-30 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.6344 | 3046971 | 721018 | 2022-09-30 | HIGH |
| Artisan Partners Limited Partnership | Investment Advisor | 1.4213 | 2649616 | -267593 | 2022-09-30 | LOW |
| Assenagon Asset Management S.A. | Investment Advisor | 1.3895 | 2590392 | -25765 | 2022-12-31 | HIGH |
| Fairmount Funds Management LLC | Hedge Fund | 1.3642 | 2543107 | -800000 | 2022-09-30 | MED |
| PFM Health Sciences, LP | Hedge Fund | 1.1599 | 2162411 | 0 | 2022-09-30 | LOW |
| BNP Paribas Asset Management USA, Inc. | Investment Advisor | 1.1316 | 2109664 | 10337 | 2022-09-30 | LOW |
| Nuveen LLC | Pension Fund | 1.0207 | 1902821 | -23013 | 2022-09-30 | LOW |
| 1919 Investment Counsel, LLC | Investment Advisor/Hedge Fund | 0.9859 | 1837874 | -3850 | 2022-09-30 | LOW |
| First Manhattan Company | Investment Advisor | 0.9683 | 1805072 | 0 | 2022-09-30 | LOW |
لماذا Capital.com هي اختيارك الأمثل؟ الأمر بسيط ! انظر إلى الأرقام وقرر بنفسك.
Capital.com Group +485000+
عدد المتداولين
65000+
عدد المتداولين النشطين شهريا
$48000000+
حجم الاستثمار شهريا
$28000000+
جرّب الآن عمليات السحب شهريا
حاسبة التداول
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
عمولة التداول
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
الرافعة المالية
20:1
- 20
- 100
- 500
- 1000
- 10000
الاستثمار
حجم الصفقة (الرافعة المالية × الاستثمار):
الفتح
الإغلاق
بيع على المكشوف شراء
| Industry: | Bio Therapeutic Drugs |
4505 Emperor Blvd Ste 200
DURHAM
NORTH CAROLINA 27703-8457
US
بيان الدخل
- Annual
- Quarterly
الناس ايضا يتابعون
هل ما زلت تبحث عن وسيط يمكنك أن تثق فيه؟
انضم إلى أكثر من 485،000متداول من جميع أنحاء العالم اختاروا التداول مع Capital.com